Registered Cardiovascular Invasive Specialist (RCIS) Practice Test

Disable ads (and more) with a membership for a one time $2.99 payment

Prepare for the Registered Cardiovascular Invasive Specialist (RCIS) Exam. Utilize flashcards and multiple-choice questions with detailed explanations. Ace your exam with confidence!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.


Which medications fall under the anti-platelet category?

  1. ReoPro and Plavix

  2. Coumadin and Lasix

  3. Heparin and NTG

  4. Lasix and Metoprolol

The correct answer is: ReoPro and Plavix

The correct choice showcases medications that are specifically designed to inhibit platelet aggregation, which is crucial in preventing blood clots that can lead to serious cardiovascular events like heart attacks and strokes. ReoPro, known generically as abciximab, is a glycoprotein IIb/IIIa inhibitor that reduces platelet aggregation during and after percutaneous coronary interventions. Plavix, or clopidogrel, is a widely used thienopyridine that irreversibly inhibits the P2Y12 receptor on platelets, thereby preventing clots from forming. In contrast, the other options include medications that serve different purposes. Coumadin (warfarin) is an anticoagulant that affects the coagulation cascade rather than directly inhibiting platelets. Lasix (furosemide) is a diuretic used to reduce fluid overload, particularly in congestive heart failure, and does not have an anti-platelet effect. Heparin is an anticoagulant, and NTG (nitroglycerin) is a vasodilator that helps relieve chest pain rather than inhibiting platelet function. Lastly, Lasix and Metoprolol (a beta-blocker) also do not belong to the anti-plate